Patents by Inventor Dongling HAO

Dongling HAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyridino[1,2-A]pyrimidone analogue used as MTOR/P13K inhibitor
    Patent number: 9868737
    Abstract: The present invention relates to novel pyridino[1,2-?]pyrimidone compounds represented by formula (I) or pharmaceutically acceptable salts thereof; and a method of use thereof for treating tumors.
    Type: Grant
    Filed: June 16, 2015
    Date of Patent: January 16, 2018
    Assignee: CISEN PHARMACEUTICAL CO., LTD.
    Inventors: Huiping Guan, Chengde Wu, Tao Yu, Lei Huang, Dongling Hao, Bo Gao, Jikui Sun, Nengyang Shi, Shuhui Chen
  • PYRIDINO[1,2-A]PYRIMIDONE ANALOGUE USED AS MTOR/P13K INHIBITOR
    Publication number: 20170129888
    Abstract: Disclosed is a pyridino[1,2-a]pyrimidone analogue used as an mTOR/PI3K inhibitor. The present invention particularly relates to a compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 16, 2015
    Publication date: May 11, 2017
    Inventors: Huiping GUAN, Chengde WU, Tao YU, Lei HUANG, Dongling HAO, Bo GAO, Jikui SUN, Nengyang SHI, Shuhui CHEN